Streamex Corp. — Director's Dealing 2023

Mar 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2023-02-24

Reporting Person: Hrkac Frederick (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-24	Common Stock	A	12000	—	Acquired	57455	Direct

Footnotes

F1: The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.